1. A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?
    Reham M. Mashat et al, 2021, Cells CrossRef
  2. Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression
    Aylin KANLI et al, 2022, Acta Medica Nicomedia CrossRef
  3. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
    Mengnan Li et al, 2024, Frontiers in Pharmacology CrossRef
  4. Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells
    Sevinc Yanar et al, 2024, Molecular Biology Reports CrossRef
  5. Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer
    Mona Kafka et al, 2020, Cancers CrossRef
  6. Simvastatin Loaded D-α-tocopherol Polyethylene Glycol 1000 Succinate Micelles Augments Cytotoxicity Against Breast Cancer Cells
    Gamal A. Shazly et al, 2020, International Journal of Pharmacology CrossRef
  7. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
    Navneet Kumar et al, 2021, Frontiers in Genetics CrossRef
  8. Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
    Adele Chimento et al, 2019, Frontiers in Endocrinology CrossRef
  9. Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity
    Nabil A. Alhakamy et al, 2020, Marine Drugs CrossRef
  10. Thymoquinone Loaded Zein Nanoparticles Improves the Cytotoxicity against Breast Cancer Cells
    Usama A. Fahmy et al, 2020, International Journal of Pharmacology CrossRef